Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

826
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
826
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

617
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
617
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

16
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
16
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

2.3K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.3K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

834
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
834
Seizures: Classification01:13

Seizures: Classification

276
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
276

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-Hypoxic Dystonia-Parkinsonism: Good Response to Levodopa and Botulinum Toxin in an Adult Patient.

Movement disorders clinical practice·2026
Same author

Sensory Tricks in Dystonia: A Systematic Review and Nested Quantitative Synthesis.

Brain and behavior·2026
Same authorSame journal

Aiming at the Seed: α-Synuclein Immunotherapy in Multiple System Atrophy.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Clinical outcomes of conservative, endovascular and microsurgical management of unruptured giant intracranial aneurysms: 3-year follow-up of the prospective, multinational Giant Intracranial Aneurysm Registry.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Voluntary Wheel Running as Refinement Tool for Postoperative Severity Assessment and Humane Endpoint Detection in Rats with Brain Tumors.

Brain sciences·2026
Same author

Orthostatic Myoclonus-Clinical and Electrophysiological Features in a Large Retrospective Cohort.

Movement disorders clinical practice·2026

Related Experiment Video

Updated: May 9, 2025

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

9.7K

Definition and Classification of Dystonia.

Alberto Albanese1,2, Kailash P Bhatia3, Victor S C Fung4

  • 1Department of Neurology, IRCCS Neurological Institute C. Mondino, Pavia, Italy.

Movement Disorders : Official Journal of the Movement Disorder Society
|May 6, 2025
PubMed
Summary

This study revises the consensus definition and classification of dystonia, a movement disorder. The updated framework aims to improve clinical recognition and management of dystonia by retaining the core definition and classification structure.

Keywords:
classificationconsensusdefinitiondystonia

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.2K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K

Related Experiment Videos

Last Updated: May 9, 2025

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

9.7K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.2K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K

Area of Science:

  • Neurology
  • Movement Disorders
  • Clinical Consensus

Background:

  • Dystonia is a complex movement disorder with diverse causes and presentations.
  • The 2013 consensus definition and classification required updating due to new research and clinical experience.
  • A standardized approach is crucial for consistent diagnosis and treatment.

Purpose of the Study:

  • To revise the 2013 consensus definition and classification of dystonia.
  • To incorporate advancements in understanding dystonia's clinical features and etiologies.
  • To facilitate uniform clinical recognition and management of dystonia.

Main Methods:

  • A panel of movement disorder specialists reviewed the 2013 consensus document.
  • The panel proposed revisions based on subsequent publications and a decade of experience.
  • Consensus was reached on retaining the core definition and two-axis classification structure.

Main Results:

  • The definition of dystonia was retained with minor wording clarifications.
  • Dystonia is defined as sustained or intermittent abnormal movements/postures, often patterned, repetitive, and triggered by voluntary action.
  • The two-axis classification (clinical characteristics and etiology) was maintained with revisions.

Conclusions:

  • The revised consensus provides an updated definition and classification for dystonia.
  • The updated framework aims to enhance clinical recognition and management of dystonia.
  • The revision promotes a uniform implementation of dystonia classification globally.